Skip to content
healthcare.dev

Metronidazole

NDC 50111-334, Metronidazole, tablet, from Teva Pharmaceuticals USA, Inc..

Product NDC
50111-334
Status
Listed
Labeler
Teva Pharmaceuticals USA, Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA070033
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/50111-334 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • METRONIDAZOLE500 mg/1

Pharmacologic classes

Nitroimidazole Antimicrobial [EPC]; Nitroimidazoles [CS]

Package NDCNDC-11Package
50111-334-0150111033401100 TABLET in 1 BOTTLE (50111-334-01)
50111-334-0250111033402500 TABLET in 1 BOTTLE (50111-334-02)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/291a45f6-ed27-4dcc-8364-358d08623797
  • NADAC price for package 50111033401

    GET /v1/drugs/nadac/50111033401
  • NADAC price for package 50111033402

    GET /v1/drugs/nadac/50111033402

Use it

Look up 50111-334 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/50111-334 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 50111-334. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.